Free Trial
CNSX:LHS

Liberty Health Sciences (LHS) Stock Price, News & Analysis

Liberty Health Sciences logo

About Liberty Health Sciences Stock (CNSX:LHS)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
1.46 million shs
Average Volume
346,771 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Liberty Health Sciences Inc. engages in the production and distribution of medical cannabis primarily in the State of Florida. It has a strategic partnership with Veterans Cannabis Project to support various research projects focused on the treatment of service related trauma with cannabis derived products; and partnership with AdaViv Inc. to enhance production of cannabis. The company is headquartered in Toronto, Canada.

Receive LHS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Liberty Health Sciences and its competitors with MarketBeat's FREE daily newsletter.

LHS Stock News Headlines

The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Game Recap: Liberty 80, Lynx 77
See More Headlines

LHS Stock Analysis - Frequently Asked Questions

Shares of LHS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Liberty Health Sciences investors own include Canopy Growth (WEED), Aphria (APHA), Aurora Cannabis (ACB), Canopy Growth (CGC), (FIRE.V) (FIRE), Aurora Cannabis (ACB) and Alkermes (ALKS).

Industry, Sector and Symbol

Stock Exchange
CNSX
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
CNSX:LHS
CIK
N/A
Fax
N/A
Employees
75
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (CNSX:LHS) was last updated on 5/17/2025 by MarketBeat.com Staff
From Our Partners